Pain Management Market Research Reports
Title | published | price | |
---|---|---|---|
Global Pain Partnering 2012 to 2018By Current Partnering "...... nts since 2012 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies.
- Trends in partnering deals
- Top deals by value
- Deals listed by comp......" | 01-Oct-2018 | $1995 | |
Global Non-Opioid Pain Treatment Market Forecast 2018-2026By Inkwood Research "...... hese are expected to propel the market growth over the projected years.
Market Insights
The global non-opioid pain treatment market is segmented on the basis of therapeutics application and products. The therapeutic applications......" | 01-Jul-2018 | $2500 | |
Visceral Pain - Pipeline Review, H1 2018By Global Markets Direct "...... l organs. Symptoms include aches, cramps and diffuse pain. Treatment includes analgesics such as narcotics or NSAIDs and pain modifiers such as tricyclic antidepressants or anticonvulsants.
Report Highlights
......" | 20-Feb-2018 | $2000 | |
Post-Operative Pain - Pipeline Review, H1 2018By Global Markets Direct "...... ing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors i......" | 18-Jan-2018 | $2000 | |
Fibromyalgia - Pipeline Review, H1 2018By Global Markets Direct "...... in accompanied by fatigue, sleep, memory and mood issues. Symptoms include fatigue, depression, headaches, and pain or cramping in the lower abdomen. The predisposing factors include family history, rheumatoid arthritis or lupus. Treatment includes p......" | 18-Jan-2018 | $2000 | |
Hyperalgesia - Pipeline Review, H1 2018By Global Markets Direct "...... e long term opioid usage, inflammation, damage to nociceptors, damage to peripheral nerves and psychological disorders. Treatment includes antidepressants and Non-steroidal anti-inflammatory drugs.
Report Highlights......" | 18-Jan-2018 | $2000 | |
Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of PainBy MP Advisors "...... s. Opioids (e.g., morphine, codeine, oxycodone) are currently one of the most potent groups of analgesics used clinically, with prescriptions increasing by 50% over the past 10 years for chronic, non-cancer pain. However, there is clear evidence that......" | 13-Jan-2015 | $3000 | |
|